AFP held fact-checking trainings before the 2025 International Fact-Checking Day

Four AFP journalists from the digital investigation department travelled to Sofia, Bucharest and Budapest, in March and April 2025 to provide fact-checking training to journalists and journalism students.

Four AFP journalists from the digital investigation department travelled to Sofia, Bucharest and Budapest, in March and April 2025 to provide fact-checking training to journalists and journalism students.
01/28/2026 12:00
Hydrostor and Baker Hughes Deepen Strategic Collaboration to Advance Reliable, Resilient, and Sustainable Power Systems

Hydrostor, a leading global long duration energy storage (LDES) developer and operator, and Baker Hughes, an energy technology company, announced Wednesday a strategic technology solutions and equity agreement. Baker Hughes will deepen its relationship with Hydrostor, integrating Baker Hughes’ technology capabilities as part of Hydrostor’s core design offering for its advanced compressed air energy storage (A-CAES) solution. This includes up to 1.4 GW of Baker Hughes equipment orders for Hydros...

Newsflare joins AFP's partner video collections

AFP announces a partnership with video agency Newsflare, which specialises in collecting, verifying and licensing UGC videos.

AFP announces a partnership with video agency Newsflare, which specialises in collecting, verifying and licensing UGC videos.
Anglais

AFP holds online workshop on verifying climate disinformation ahead of COP30 in Brazil

AFP held a digital investigation workshop on Wednesday 12 February for Brazilian journalists preparing to cover the COP30 – the 30th session of the UN climate change conference –, to be held in November 2025 in the Amazon, in the city of Belém.

AFP held a digital investigation workshop on Wednesday 12 February for Brazilian journalists preparing to cover the COP30 – the 30th session of the UN climate change conference –, to be held in November 2025 in the Amazon, in the city of Belém.

Mehdi Lebouachera appointed AFP’s next Global Editor-In-Chief

Mehdi Lebouachera has been appointed as AFP’s next Global Editor-In-Chief, replacing Sophie Huet, who is taking on a new role developing the agency’s Artificial Intelligence strategy.

Mehdi Lebouachera has been appointed as AFP’s next Global Editor-In-Chief, replacing Sophie Huet, who is taking on a new role developing the agency’s Artificial Intelligence strategy.
Anglais
01/28/2026 12:50
Veracode Releases Platform Enhancements as Software Supply Chain Attacks Surge

Veracode, the global leader in application risk management, today announced significant platform innovations introduced through the second half of 2025. Headlining the release is Package Firewall, an industry-leading preventive control for software supply chains, advancing the company’s mission to help organizations run secure software from code to cloud. With supply chain-related third-party breaches doubling year over year— from 15 to 30 percent according to the Verizon 2025 Data Breach Inves...

AFP partners with Athens Photo World photojournalism festival

The annual Athens Photo World festival, taking place from 25 June to 31 August 2025 in the Greek capital, is hosting an outdoor exhibition of AFP photography on the railings of the city’s National Garden.

The annual Athens Photo World festival, taking place from 25 June to 31 August 2025 in the Greek capital, is hosting an outdoor exhibition of AFP photography on the railings of the city’s National Garden.
Anglais
12/04/2025 08:00
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes

LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collabora...